This initiative, spearheaded by Tom Laughlin, executive vice president, sales and marketing, follows over a year of internal and external research that has yielded clear evidence of the company’s strengths and how these strengths fulfill industry values and expectations. Abelson Taylor, the Chicago-based award-winning medical/pharmaceutical advertising agency, assisted MPI Research in developing its branding initiative.

William U Parfet, CEO and chairman of MPI Research, said, “The biotech and pharmaceutical industries have undergone substantial transformation over the past 18 months, and we have realigned our organization to better serve them. In response to this changing environment, we have freshened our look and redefined our positioning in the marketplace. Sponsors have always told us that the caring, flexible and solution-focused employees of MPI Research stand out in the industry. Our new branding accentuates how these important attributes, coupled with our scientific experience and expertise, create significant value for our sponsors as we assist them in moving their drugs and medical devices forward.”

MPI Research, with global headquarters in Mattawan, Mich., provides discovery, safety evaluation, bioanalytical and analytical services to the biopharmaceutical, medical device, animal health and chemical industries. Scientific knowledge and experience, integrity, trust, teamwork, and dedication to strong and enduring Sponsor relationships characterise MPI Research as a high-performance, high-quality, responsive organisation that is committed to bringing safer and more effective products to the world.